Global Markets Direct’s, Diabetic Nephropathy Pipeline Review, H2 2014′, provides an overview of the Diabetic Nephropathy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Nephropathy, complete with comparative analysis at various stages, therapeutics assessment by […]
September 2014 Life Science Industry Research Reports
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2014
Global Markets Direct’s, Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Pipeline Review, H2 2014′, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Myelocytic […]
Dengue – Pipeline Review, H2 2014
Global Markets Direct’s, Dengue Pipeline Review, H2 2014′, provides an overview of the Dengue’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism […]
Renal Cell Carcinoma – Pipeline Review, H2 2014
Global Markets Direct’s, Renal Cell Carcinoma Pipeline Review, H2 2014′, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Renal Cell Carcinoma, complete with comparative analysis at various stages, […]
Metastatic Melanoma – Pipeline Review, H2 2014
Global Markets Direct’s, Metastatic Melanoma Pipeline Review, H2 2014′, provides an overview of the Metastatic Melanoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Melanoma, complete with comparative analysis at various stages, therapeutics assessment by […]
Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2014
Global Markets Direct’s, Chronic Lymphocytic Leukemia (CLL) Pipeline Review, H2 2014′, provides an overview of the Chronic Lymphocytic Leukemia (CLL)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Lymphocytic Leukemia (CLL), complete with comparative analysis […]
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H2 2014
Global Markets Direct’s, Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Pipeline Review, H2 2014′, provides an overview of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections, complete […]
Multiple Myeloma (Kahler’s Disease) – Pipeline Review, H2 2014
Global Markets Direct’s, Multiple Myeloma (Kahler’s Disease) Pipeline Review, H2 2014′, provides an overview of the Multiple Myeloma (Kahler’s Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Multiple Myeloma (Kahler’s Disease), complete with comparative analysis […]
Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2014
Global Markets Direct’s, Glioblastoma Multiforme (GBM) Pipeline Review, H2 2014′, provides an overview of the Glioblastoma Multiforme (GBM)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Glioblastoma Multiforme (GBM), complete with comparative analysis at various stages, […]
Obesity – Pipeline Review, H2 2014
Global Markets Direct’s, Obesity Pipeline Review, H2 2014′, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Obesity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism […]
Stay In Touch